[
    [
        {
            "time": "2020-04",
            "original_text": "医药-2020年4月疫苗批签发数据跟踪：行业整体批签发量持续增长 上市公司核心产品维持高速增长",
            "features": {
                "keywords": [
                    "疫苗",
                    "批签发",
                    "增长",
                    "上市公司",
                    "核心产品"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药-2020年4月疫苗批签发数据跟踪：行业整体批签发量持续增长 上市公司核心产品维持高速增长",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 3,
                "Headline_Structure": 6,
                "Source_Recency": 3
            }
        },
        {
            "time": "2020-05-13",
            "original_text": "【朝闻国盛0513】通胀无虞，北上延续流入",
            "features": {
                "keywords": [
                    "通胀",
                    "北上资金",
                    "流入"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "宏观经济"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "【朝闻国盛0513】通胀无虞，北上延续流入",
                "Correlation": 4,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 2,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 4
            }
        },
        {
            "time": "2020-05",
            "original_text": "沃森生物与苏州艾博合作研发mRNA疫苗，研发加速助力长期发展",
            "features": {
                "keywords": [
                    "沃森生物",
                    "mRNA疫苗",
                    "研发",
                    "长期发展"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "沃森生物与苏州艾博合作研发mRNA疫苗，研发加速助力长期发展",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2020-05",
            "original_text": "监管部门表示关注 沃森生物'佛系'大股东刘俊辉3亿定增康泰生物很'狼性'",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大股东",
                    "刘俊辉",
                    "定增",
                    "康泰生物"
                ],
                "sentiment_score": -0.3,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "监管部门表示关注 沃森生物'佛系'大股东刘俊辉3亿定增康泰生物很'狼性'",
                "Correlation": 9,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "2020-05",
            "original_text": "沃森生物大股东被动上位1个月就拟减持 转头认购同行股票 控制人变化",
            "features": {
                "keywords": [
                    "沃森生物",
                    "大股东",
                    "减持",
                    "同行股票",
                    "控制人变化"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "沃森生物大股东被动上位1个月就拟减持 转头认购同行股票 控制人变化",
                "Correlation": 10,
                "Sentiment": 4,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        }
    ]
]